Soluble tumor necrosis factor receptors--their properties and role in diagnosis and therapy of acute and chronic diseases
Kokot, T.; Muc-Wierzgoń, M.; Zubelewicz, B.; Wierzgoń, J.; Nowakowska, E.; Brodziak, A.
Postepy Higieny i Medycyny Doswiadczalnej 54(5): 585-596
2000
ISSN/ISBN: 0032-5449 PMID: 11146887 Document Number: 517348
The review presents the properties and significance of soluble forms of tumor necrosis factor-alpha receptors in physiology and pathology of human organism. Special attention was turned to the possibility of practical application of those forms of the receptors in the therapy of diseases caused by excessive activity of TNF-alpha. The significance of the soluble receptors as prognostic factors of disease progression and outcome was stressed.
Document emailed within 1 workday
Related Documents
Schmidt, K.L. 2000: Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases Journal of Rheumatology 27(9): 2281-2282Rullan, P.; Murase, J. 2009: Two cases of chronic atopic dermatitis treated with soluble tumor necrosis factor receptor therapy Journal of Drugs in Dermatology: Jdd 8(9): 873-876
Tziakas, D.; Chalikias, G.; Parissis, J.T.; Hatzinikolaou, H.; Stakos, D.; Papadopoulou, E.; Kortsaris, A.; Hatseras, D. 2004: Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3 European Cytokine Network 15(3): 231-239
Krichevskaia, O.A.; Kliukvina, N.G.; Aleksandrova, E.N.; Samsonov, M.I.; Nasonov, E.L. 2004: Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus Klinicheskaia Meditsina 82(10): 51-55
García, M.Martin.; De Rissio, A.Maria.; Villalonga, X.; Mengoni, E.; Cardoni, R.L. 2008: Soluble tumor necrosis factor (TNF) receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children American Journal of Tropical Medicine and Hygiene 78(3): 499-503
Sorkine, P.; Setton, A.; Halpern, P.; Miller, A.; Rudick, V.; Marmor, S.; Klausner, J.M.; Goldman, G. 1995: Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration Critical Care Medicine 23(8): 1377-1381
Kacprzyk, F. 2002: Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis Polskie Archiwum Medycyny Wewnetrznej 107(3): 215-221
Mohler, K.M.; Torrance, D.S.; Smith, C.A.; Goodwin, R.G.; Stremler, K.E.; Fung, V.P.; Madani, H.; Widmer, M.B. 1993: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists Journal of Immunology 151(3): 1548-1561
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Pizzo, P.; Murgia, M.; Zambon, A.; Zanovello, P.; Bronte, V.; Pietrobon, D.; Di Virgilio, F. 1992: Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts Journal of Immunology 149(10): 3372-3378
Segura Fernández, E.; Domenech Cienfuegos, I.; Pérez Guzmán, E.; Guerrero Sánchez, F.; Escribano Moriana, J.C.; Pérez Cano, R.; Fernández-Gutiérrez del Alamo, C.; Girón González, J.A. 1999: Serial assessment of the nutritional status of patients infected by the human immunodeficiency virus. Role of tumor necrosis factor/its receptors Revista Clinica Espanola 199(12): 790-795
Kristiansson, M.; Soop, M.; Shanwell, A.; Sundqvist, K.G. 1996: Prestorage versus bedside white blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors Journal of Trauma 40(3): 379-383
Egido, J.; Gómez-Chiarri, M.; Ortíz, A.; Bustos, C.; Alonso, J.; Gómez-Guerrero, C.; Gómez-Garre, D.; López-Armada, M.J.; Plaza, J.; Gonzalez, E. 1993: Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases Kidney International. Suppl 39: S59-S64
Kaneko, H.; Yamada, H.; Mizuno, S.; Udagawa, T.; Kazumi, Y.; Sekikawa, K.; Sugawara, I. 1999: Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Laboratory Investigation; a Journal of Technical Methods and Pathology 79(4): 379-386
Perskidskiĭ, I.V.; Barshteĭn, I.A. 1992: Biological manifestations of the tumor necrosis factor effect and its role in the pathogenesis of various diseases Arkhiv Patologii 54(2): 5-10
Serwin, A.B.; Flisiak, I.; Chodynicka, B. 2004: The role of tumor necrosis factor alpha receptors (TNF-alpha) in psoriasis and other skin disorders Wiadomosci Lekarskie 57(11-12): 686-690
Nassonov, E.L.; Samsonov, M.Y.; Tilz, G.P.; Beketova, T.V.; Semenkova, E.N.; Baranov, A.; Wachter, H.; Fuchs, D. 1997: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis Journal of Rheumatology 24(4): 666-670
Takemura, M.; Saito, K.; Seishima, M. 2005: Soluble tumor necrosis factor receptor I, Ii Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 158-160
Pfeffer, K. 2000: Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands European Cytokine Network 11(3): 514
Girolomoni, G.; Pastore, S.; Albanesi, C.; Cavani, A. 2002: Targeting tumor necrosis factor-alpha as a potential therapy in inflammatory skin diseases Current Opinion in Investigational Drugs 3(11): 1590-1595